: Global medical cannabis now accounts for 81% of total revenue and 95% of adjusted gross profit , with medical margins holding steady at 69% . Market Sentiment & Ratings
: Reported $15.5 million in free cash flow for Q3 fiscal 2026, a critical milestone for long-term sustainability. buy acb stock
Aurora has demonstrated improving operational metrics despite bottom-line volatility. : Global medical cannabis now accounts for 81%
Professional outlooks on ACB are mixed, balancing its medical leadership against broader sector risks. Professional outlooks on ACB are mixed, balancing its
As of April 28, 2026, Aurora Cannabis (ACB) is trading at , reflecting a 19.12% decline year-to-date . The company is currently executing a strategic shift to prioritize high-margin global medical cannabis markets over lower-margin consumer segments. Aurora Cannabis Inc (ACB) -19.12% since Jan 2, 2026 Closed: 4:00 PM • Disclaimer After hours: 7:30 PM Apr 27, 2026 Mkt cap$271.06M CAD 52-wk high6.67 P/E ratio- 52-wk low3.07 Div yield- Financial Performance & Health
Should You Buy, Hold or Sell ACB Stock Post Q3 Earnings Release?